Cargando…

Emerging Anti-Diabetic Drugs for Beta-Cell Protection in Type 1 Diabetes

Type 1 diabetes (T1D) is a chronic autoimmune disorder that damages beta cells in the pancreatic islets of Langerhans and results in hyperglycemia due to the loss of insulin. Exogenous insulin therapy can save lives but does not halt disease progression. Thus, an effective therapy may require beta-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajmal, Nida, Bogart, Maislin C., Khan, Palwasha, Max-Harry, Ibiagbani M., Nunemaker, Craig S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253164/ https://www.ncbi.nlm.nih.gov/pubmed/37296593 http://dx.doi.org/10.3390/cells12111472

Ejemplares similares

Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes
por: Nunemaker, Craig S.
Publicado: (2016)

A Putative Prohibitin-Calcium Nexus in β-Cell Mitochondria and Diabetes
por: Verma, Gaurav, et al.
Publicado: (2020)

Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice
por: Lee, Jason T. C., et al.
Publicado: (2018)

Manganese-Enhanced Magnetic Resonance Imaging Detects Declining Pancreatic β-Cell Mass in a Cyclophosphamide-Accelerated Mouse Model of Type 1 Diabetes
por: Antkowiak, Patrick F., et al.
Publicado: (2013)

SUN-187 Dolutegravir Causing Diabetes
por: Kamal, Palwasha, et al.
Publicado: (2019)

Prevalence of Type II diabetes in District Dir Lower in Pakistan
por: Akhtar, Sohail, et al.
Publicado: (2016)

Neratinib protects pancreatic beta cells in diabetes
por: Ardestani, Amin, et al.
Publicado: (2019)

The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis
por: Benninger, Richard K. P., et al.
Publicado: (2018)

Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs
por: Saine, M Elle, et al.
Publicado: (2015)

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
por: Häggström, Christel, et al.
Publicado: (2016)

Reducing Glucokinase Activity to Enhance Insulin Secretion: A Counterintuitive Theory to Preserve Cellular Function and Glucose Homeostasis
por: Whitticar, Nicholas B., et al.
Publicado: (2020)

Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications
por: Zhang, Xueli, et al.
Publicado: (2021)

Pharmacogenetics of Anti-Diabetes Drugs
por: DiStefano, Johanna K., et al.
Publicado: (2010)

Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
por: Coomans de Brachène, Alexandra, et al.
Publicado: (2022)

Type 2 Diabetes and the Aging Pancreatic Beta Cell
por: Gunasekaran, Uma, et al.
Publicado: (2011)

Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells
por: Gurgul-Convey, Ewa
Publicado: (2020)

Systematic Biophysical Insights into the Interaction of Anti MERS-CoV Drug Ribavirin with Major Transport Protein in Human Serum: In-Vitro Studies and Implications in Diabetes and Uremia
por: Almutairi, Fahad, et al.
Publicado: (2019)

Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice
por: Son, Dong Ju, et al.
Publicado: (2015)

Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment
por: Zhang, Zaijun, et al.
Publicado: (2009)

Editorial: Heterogeneity of clinical phenotypes in type 1 diabetes and of beta cell deterioration in type 1 diabetes
por: Li, Xia, et al.
Publicado: (2023)

Emerging Targets in Type 2 Diabetes and Diabetic Complications
por: Demir, Sevgican, et al.
Publicado: (2021)

Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial
por: Qasim, Rubina, et al.
Publicado: (2020)

Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2019)

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models
por: Wirth, Fabian, et al.
Publicado: (2023)

Hypoglycemic, Hypolipidemic, and Anti-Inflammatory Effects of Beta-Pinene in Diabetic Rats
por: Santos, Enaide Soares, et al.
Publicado: (2022)

Policy Intervention and Financial Sustainability in an Emerging Economy: A Structural Vector Auto Regression Analysis
por: Ahmed, Sarah, et al.
Publicado: (2022)

The revolution of the anti-diabetic drugs in cardiology
por: Verdecchia, Paolo, et al.
Publicado: (2020)

Effectiveness of Telemedicine for the Management of Foot Ulcers in People With Diabetes: A Meta-Analysis
por: Khan, Ushna, et al.
Publicado: (2022)

Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
por: Saisho, Yoshifumi
Publicado: (2014)

Pancreatic beta cell autophagy is impaired in type 1 diabetes
por: Muralidharan, Charanya, et al.
Publicado: (2021)

The Role of Beta Cell Recovery in Type 2 Diabetes Remission
por: Suleiman, Mara, et al.
Publicado: (2022)

Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes
por: Yang, Mei-Ling, et al.
Publicado: (2022)

Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model
por: Murai, Yasutaka, et al.
Publicado: (2017)

Joint effects of diabetic-related genomic loci on the therapeutic efficacy of oral anti-diabetic drugs in Chinese type 2 diabetes patients
por: Chen, Miao, et al.
Publicado: (2016)

Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes
por: Mori, Takahiro, et al.
Publicado: (2021)

Genome scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes
por: Cai, Erica P., et al.
Publicado: (2020)

Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies
por: Costes, Safia, et al.
Publicado: (2021)

Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
por: Singh, Kailash, et al.
Publicado: (2022)

Zinc transporter 8 haploinsufficiency protects against beta cell dysfunction in type 1 diabetes by increasing mitochondrial respiration
por: Kim, Yong Kyung, et al.
Publicado: (2022)

Spirulina Extract Enhanced a Protective Effect in Type 1 Diabetes by Anti-Apoptosis and Anti-ROS Production
por: Lee, Jiyeong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_esqdr2n2238psoflj1vi0eeci9